Focused Wealth Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-800
| Closed | -$51K | – | 835 |
|
|
2020
Q2 | $51K | Sell |
800
-375
| -32% | -$23.9K | 0.01% | 303 |
|
|
2020
Q1 | $60K | Sell |
1,175
-10
| -0.8% | -$511 | 0.02% | 268 |
|
|
2019
Q4 | $94K | Sell |
1,185
-2,255
| -66% | -$179K | 0.02% | 259 |
|
|
2019
Q3 | $167K | Buy |
3,440
+300
| +10% | +$14.6K | 0.05% | 160 |
|
|
2019
Q2 | $165K | Hold |
3,140
| – | – | 0.04% | 166 |
|
|
2019
Q1 | $166K | Hold |
3,140
| – | – | 0.05% | 150 |
|
|
2018
Q4 | $129K | Buy |
3,140
+400
| +15% | +$16.4K | 0.04% | 191 |
|
|
2018
Q3 | $104K | Buy |
+2,740
| New | +$104K | 0.04% | 226 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 719 |
|
|
2018
Q1 | – | Sell |
-6,400
| Closed | -$252K | – | 737 |
|
|
2017
Q4 | $252K | Buy |
+6,400
| New | +$252K | 0.08% | 123 |
|